Bruni, Pia Simona; Eberle, Rahel; Schürch, Stefan (25 October 2018). Investigation of the cyclopentadienyl loss of titanocene-DNA adducts in negative ESI-MS/MS (Unpublished). In: Annual Meeting of the Swiss Group for Mass Spectrometry (SGMS). Beatenberg, Switzerland. October 25-26, 2018.
Metallocenes and their derivatives have been found to be a promising alternative to the widely used platinum-based anticancer drugs. Same as platinum-based agents, metallocenes, such as Titanocene dichloride (Cp2TiCl2, Cp = cyclopentadienyl), bind to nuclear DNA, inhibiting the cell replication and, therefore, reducing the growth of the cancer cells.
Current investigations with positive ESI-MS/MS on the binding mechanism of titanocene have revealed the phosphate group adjacent to a thymine nucleobase as favored binding site. In contrast to the backbone fragmentation occurring after CID of cationic adducts ([M+Cp2Ti]n+), CID of cationic titanocene-DNA adducts ([M+Cp2Ti]n-) lead to the loss of the cyclopentadienyl ligands and only minor backbone scission. On closer consideration, the resulting ion was identified as the odd-electron titanium-DNA adduct [M+Ti]n-•. This implies that one cyclopentadienyl is lost as C5H5•, whereas the other is released as C5H6. High-resolution tandem Mass Spectrometry has been used to further investigate this unusual electron transfer during the ligand loss as well as the localization of the remaining unpaired electron.
Item Type: |
Conference or Workshop Item (Poster) |
|---|---|
Division/Institute: |
08 Faculty of Science > Department of Chemistry, Biochemistry and Pharmaceutical Sciences (DCBP) |
UniBE Contributor: |
Bruni, Pia Simona, Eberle, Rahel, Schürch, Stefan |
Subjects: |
500 Science > 570 Life sciences; biology 500 Science > 540 Chemistry 500 Science |
Language: |
English |
Submitter: |
Stefan Schürch |
Date Deposited: |
19 Sep 2019 13:53 |
Last Modified: |
05 Dec 2022 15:29 |
URI: |
https://boris.unibe.ch/id/eprint/131470 |
Actions (login required)
 |
Edit item |